Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Albuminar, Albuminar-20, Albuminar-25, Albuminar-5

Last content change checked dailysee data sync status

Active ingredient
albumin (human) 5 G/20 mL – 25 G/500 mL
Other brand names
Dosage form
Injection
Route
Intravenous
Prescription status
Rx (prescription)
Marketed in the U.S.
Since 2000
Active ingredient
albumin (human) 5 G/20 mL – 25 G/500 mL
Other brand names
Dosage form
Injection
Route
Intravenous
Prescription status
Rx (prescription)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2000
Manufacturer
CSL Behring LLC
Registration number
BLA103955
Biosimilarity information
Biosimilarity information

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Biosimilarity

Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 is the FDA‑licensed reference product against which biosimilar and interchangeable products are compared.

Product PresentationBiosimilarity Status
Single-Dose Vial5G/20mL
    5G/20mL
      Reference product
        Single-Dose Vial10G/50mL
          10G/50mL
            Reference product
              Single-Dose Vial12.5G/50mL
                12.5G/50mL
                  Reference product
                    Single-Dose Vial2.5G/50mL
                      2.5G/50mL
                        Reference product
                          Single-Dose Vial20G/100mL
                            20G/100mL
                              Reference product
                                Single-Dose Vial25G/100mL
                                  25G/100mL
                                    Reference product
                                      Single-Dose Vial12.5G/250mL
                                        12.5G/250mL
                                          Reference product
                                            Single-Dose Vial25G/500mL
                                              25G/500mL
                                                Reference product

                                                  Biosimilarity

                                                  Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 is the FDA‑licensed reference product against which biosimilar and interchangeable products are compared.

                                                  Product PresentationBiosimilarity Status
                                                  Single-Dose Vial5G/20mL
                                                    5G/20mL
                                                      Reference product
                                                        Single-Dose Vial10G/50mL
                                                          10G/50mL
                                                            Reference product
                                                              Single-Dose Vial12.5G/50mL
                                                                12.5G/50mL
                                                                  Reference product
                                                                    Single-Dose Vial2.5G/50mL
                                                                      2.5G/50mL
                                                                        Reference product
                                                                          Single-Dose Vial20G/100mL
                                                                            20G/100mL
                                                                              Reference product
                                                                                Single-Dose Vial25G/100mL
                                                                                  25G/100mL
                                                                                    Reference product
                                                                                      Single-Dose Vial12.5G/250mL
                                                                                        12.5G/250mL
                                                                                          Reference product
                                                                                            Single-Dose Vial25G/500mL
                                                                                              25G/500mL
                                                                                                Reference product
                                                                                                  Data Generation & Sources

                                                                                                  This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Albuminar, Albuminar-20, Albuminar-25, Albuminar-5, retrieved by a validated AI data-extraction workflow.

                                                                                                  All FDA-licensed dosage forms and strengths are listed in the Packaging & NDC Codes section above. Biosimilarity and interchangeability details appear in the Biosimilarity Information section above. Regulatory status and reference/interchangeability data were cross-checked against the FDA Purple Book (BLA103955) and the NSDE NDC Directory daily file.

                                                                                                  Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

                                                                                                  No human clinician has reviewed this version.

                                                                                                  Learn more in our Editorial Policy

                                                                                                  Last AI update:

                                                                                                  Primary FDA sources:

                                                                                                  Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

                                                                                                  Purple Book data shown on this page are limited to biosimilarity status — specifically, whether a product is designated as a Biosimilar, Interchangeable, or the Reference Product. For biosimilars and interchangeable biologics, the corresponding reference product information is also sourced directly from the FDA Purple Book.

                                                                                                  Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

                                                                                                  Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.